The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...

Anti-inflammatory drugs were linked to a reduced risk of dementia. Antibiotics, antivirals and vaccines, such as for ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Repurposing current drugs to tackle dementia is an ‘urgent priority’, academics say, but other experts warn more work is ...

“Viral and bacterial infectious causes of common dementias have been proposed, supported by epidemiological data linking ...